Protein 1 | Protein 2 | Combine Score |
---|---|---|
BNIP3 | RHEB | 0.975 |
BNIP3 | GABARAPL1 | 0.943 |
BNIP3 | BCL2L1 | 0.933 |
BNIP3 | GABARAP | 0.929 |
BNIP3 | GABARAPL2 | 0.924 |
GABARAP | GABARAPL2 | 0.909 |
GABARAPL1 | GABARAPL2 | 0.905 |
GABARAP | GABARAPL1 | 0.903 |
# | 664 (BNIP3) | 11337 (GABARAP) | 23710 (GABARAPL1) | 6009 (RHEB) | 598 (BCL2L1) | 11345 (GABARAPL2) |
---|---|---|---|---|---|---|
664 (BNIP3) | 1.00 | 0.74 | 0.74 | 0.56 | 0.89 | 0.73 |
11337 (GABARAP) | 0.74 | 1.00 | 0.97 | 0.52 | 0.71 | 0.92 |
23710 (GABARAPL1) | 0.74 | 0.97 | 1.00 | 0.54 | 0.71 | 0.90 |
6009 (RHEB) | 0.56 | 0.52 | 0.54 | 1.00 | 0.55 | 0.56 |
598 (BCL2L1) | 0.89 | 0.71 | 0.71 | 0.55 | 1.00 | 0.70 |
11345 (GABARAPL2) | 0.73 | 0.92 | 0.90 | 0.56 | 0.70 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BNIP3 | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 13 | RT-qPCR | Western US | C57BL/6 mice | 4.3 | 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
BNIP3 | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 30.6 | RT-qPCR | Western US | C57BL/6 mice | 4.3 | 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT000305 | hsa-miR-145-5p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Microarray//qRT-PCR | Functional MTI (Weak) | 22815788 |
MIRT000305 | hsa-miR-145-5p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 20332243 |
MIRT004753 | hsa-miR-221-3p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Luciferase reporter assay//Microarray//qRT-PCR//Western blot | Functional MTI | 20018759 |
MIRT437693 | hsa-miR-27a-3p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Microarray//qRT-PCR | Functional MTI (Weak) | 22815788 |
MIRT437701 | hsa-miR-27b-3p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Microarray//qRT-PCR | Functional MTI (Weak) | 22815788 |
MIRT437785 | hsa-miR-210-3p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23688833 |
MIRT733973 | hsa-miR-34a-5p | Homo sapiens | BNIP3 | 664 | Homo sapiens | PCR array | Functional MTI (Weak) | 28097098 |
MIRT734397 | hsa-miR-103a-3p | Homo sapiens | BNIP3 | 664 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 26000071 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
664 | GO:0006915 | apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0008626 | granzyme-mediated apoptotic signaling pathway | GOTERM_BP_DIRECT |
664 | GO:0005654 | nucleoplasm | GOTERM_CC_DIRECT |
664 | GO:0005741 | mitochondrial outer membrane | GOTERM_CC_DIRECT |
664 | GO:0010637 | negative regulation of mitochondrial fusion | GOTERM_BP_DIRECT |
664 | GO:0043065 | positive regulation of apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0050873 | brown fat cell differentiation | GOTERM_BP_DIRECT |
664 | GO:0051402 | neuron apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0071279 | cellular response to cobalt ion | GOTERM_BP_DIRECT |
664 | GO:0072593 | reactive oxygen species metabolic process | GOTERM_BP_DIRECT |
664 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria | GOTERM_BP_DIRECT |
664 | GO:0046982 | thyroid hormone receptor binding | GOTERM_MF_DIRECT |
664 | GO:0031307 | integral component of mitochondrial outer membrane | GOTERM_CC_DIRECT |
664 | GO:0008219 | cell death | GOTERM_BP_DIRECT |
664 | GO:0043066 | negative regulation of apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0043068 | positive regulation of programmed cell death | GOTERM_BP_DIRECT |
664 | GO:0010508 | positive regulation of autophagy | GOTERM_BP_DIRECT |
664 | GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | GOTERM_BP_DIRECT |
664 | GO:0043243 | positive regulation of protein complex disassembly | GOTERM_BP_DIRECT |
664 | GO:2000378 | negative regulation of reactive oxygen species metabolic process | GOTERM_BP_DIRECT |
664 | GO:0035694 | mitochondrial protein catabolic process | GOTERM_BP_DIRECT |
664 | GO:0045837 | negative regulation of membrane potential | GOTERM_BP_DIRECT |
664 | GO:0060548 | negative regulation of cell death | GOTERM_BP_DIRECT |
664 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
664 | GO:0005740 | mitochondrial envelope | GOTERM_CC_DIRECT |
664 | GO:0014069 | postsynaptic density | GOTERM_CC_DIRECT |
664 | GO:0048102 | autophagic cell death | GOTERM_BP_DIRECT |
664 | GO:0055093 | response to hyperoxia | GOTERM_BP_DIRECT |
664 | GO:0071260 | cellular response to mechanical stimulus | GOTERM_BP_DIRECT |
664 | GO:0001666 | response to hypoxia | GOTERM_BP_DIRECT |
664 | GO:0051607 | defense response to virus | GOTERM_BP_DIRECT |
664 | GO:0070301 | cellular response to hydrogen peroxide | GOTERM_BP_DIRECT |
664 | GO:0051020 | mitogen-activated protein kinase binding | GOTERM_MF_DIRECT |
664 | GO:0046902 | regulation of mitochondrial membrane permeability | GOTERM_BP_DIRECT |
664 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia | GOTERM_BP_DIRECT |
664 | GO:0030425 | dendrite | GOTERM_CC_DIRECT |
664 | GO:0090141 | positive regulation of mitochondrial fission | GOTERM_BP_DIRECT |
664 | GO:0042803 | protein homodimerization activity | GOTERM_MF_DIRECT |
664 | GO:0000422 | mitophagy | GOTERM_BP_DIRECT |
664 | GO:0016239 | positive regulation of macroautophagy | GOTERM_BP_DIRECT |
664 | GO:0005634 | nucleus | GOTERM_CC_DIRECT |
664 | GO:0005635 | nuclear envelope | GOTERM_CC_DIRECT |
664 | GO:0031966 | mitochondrial membrane | GOTERM_CC_DIRECT |
664 | GO:0097345 | mitochondrial outer membrane permeabilization | GOTERM_BP_DIRECT |
664 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
664 | GO:0005783 | endoplasmic reticulum | GOTERM_CC_DIRECT |
664 | GO:1901998 | toxin transport | GOTERM_BP_DIRECT |
664 | GO:0042802 | ATPase coupled ion transmembrane transporter activity | GOTERM_MF_DIRECT |
664 | GO:0005739 | mitochondrion | GOTERM_CC_DIRECT |
664 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
664 | GO:1903715 | regulation of aerobic respiration | GOTERM_BP_DIRECT |
664 | GO:0071456 | cellular response to hypoxia | GOTERM_BP_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
BNIP3 | 664 | Malignant neoplasm of prostate | C0376358 | Neoplastic Process | 0.32 | 0.569 | 0.621 | disease |
BNIP3 | 664 | Prostatic Neoplasms | C0033578 | Neoplastic Process | 0.31 | 0.569 | 0.621 | group |
BNIP3 | 664 | Hereditary Diffuse Gastric Cancer | C1708349 | Neoplastic Process | 0.3 | 0.569 | 0.621 | disease |
BNIP3 | 664 | Multiple Myeloma | C0026764 | Neoplastic Process | 0.32 | 0.569 | 0.621 | disease |
BNIP3 | 664 | Malignant neoplasm of stomach | C0024623 | Neoplastic Process | 0.31 | 0.569 | 0.621 | disease |
BNIP3 | 664 | Manganese Poisoning | C0677050 | Injury or Poisoning | 0.3 | 0.569 | 0.621 | disease |
BNIP3 | 664 | Stomach Neoplasms | C0038356 | Neoplastic Process | 0.3 | 0.569 | 0.621 | group |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|